Preferred Label : cenegermin;

UNII : B6E7K36KT8;

Details


Main resources

You can consult :


https://www.has-sante.fr/portail/jcms/c_2820103/fr/oxervate-cenegermine-forme-recombinante-du-facteur-de-croissance-des-cellules-nerveuses-humain
https://www.has-sante.fr/portail/jcms/c_2820103/fr/oxervate
2018
false
false
false
France
French
treatment outcome
nerve growth factor
Neurotrophic keratopathy
keratitis
adult
ophthalmic solutions
administration, ophthalmic
recombinant proteins
recombinant proteins
cenegermin
evaluation of the transparency committee
guidelines for drug use
cenegermin

---
Oxervate cenegermin
https://www.ema.europa.eu/medicines/human/EPAR/Oxervate
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
nerve growth factor
orphan drug production
Neurotrophic keratopathy
keratitis
adult
ophthalmic solutions
administration, ophthalmic
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
recombinant proteins
recombinant proteins
cenegermin
cenegermin
cenegermin
nerve growth factor
nerve growth factor

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.